Enimmune corporation Revenue

In the year 2024, Enimmune corporation had annual revenue of 39.92M TWD, down -8.23%. Enimmune corporation had revenue of 9.79M in the quarter ending December 31, 2024, a decrease of -35.76%.

Revenue

39.92M

Revenue Growth

-8.23%

P/S Ratio

27.02

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.08B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.92M	-3.58M	-8.23%
Dec 31, 2023	43.49M	-144.92M	-76.92%
Dec 31, 2022	188.42M	78.59M	71.56%
Dec 31, 2021	109.82M	86.95M	380.08%
Dec 31, 2020	22.88M	20.93M	1,076.75%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	40.47M
PharmaEssentia	11.34B
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	87.67M
Oneness Biotech	117.33M
Center Laboratories	1.63B
Lumosa Therapeutics	43.59M

Revenue Rankings